Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerance of "on Line" Hemodiafiltration and Impact on Morbidity and Cardiovascular Risk Factors in Chronic Renal Failure Patients

NCT01327391 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT01327391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01327391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerance of "on Line" Hemodiafiltration and Impact on Morbidity and Cardiovascular Risk Factors in Chronic Renal Failure Patients
Lead sponsor
University Hospital, Montpellier
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2005
Completion date
May 31, 2014
Enrollment
415 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease